Hypoxia regulation of ATP13A2 (PARK9) gene transcription

Journal of Neurochemistry

Volumn 122, Issue 2, 2012, Pages 251-259

  Xu, Qian ^a   Guo, Hongling ^a   Zhang, Xiaojie ^a   Tang, Beisha ^b   Cai, Fang ^a   Zhou, Weihui ^c   Song, Weihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Gene regulation; hypoxia; PARK9; Parkinson disease

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL CELL; ARTICLE; ATP13A2 GENE; CELL HYPOXIA; CELL STRAIN HEK293; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOPAMINERGIC NERVE CELL; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA RESPONSE ELEMENT; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; HYPOXIA, BRAIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTON-TRANSLOCATING ATPASES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84863336321     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07676.x     Document Type: Article

References (40)

1. Ambrosini G., Nath A. K., Sierra-Honigmann M. R., and, Flores-Riveros J., (2002) Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J. Biol. Chem. 277, 34601-34609.
2. Behrens M. I., Bruggemann N., Chana P., et al. (2010) Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov. Disord. 25, 1929-1937.
3. Beyer S., Kristensen M. M., Jensen K. S., Johansen J. V., and, Staller P., (2008) The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283, 36542-36552.
4. Bonifati V., Rizzu P., van Baren M. J., et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259. (Pubitemid 36131051)
5. Bruggemann N., Hagenah J., Reetz K., et al. (2010) Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch. Neurol. 67, 1357-1363.
6. Cavanaugh J. E., Jaumotte J. D., Lakoski J. M., and, Zigmond M. J., (2006) Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J. Neurosci. Res. 84, 1367-1375. (Pubitemid 44654460)
7. Chen W. Y., and, Chang M. S., (2009) IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J. Immunol. 182, 5003-5012.
8. Chen N., Chen X., Huang R., et al. (2009) BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}. J. Biol. Chem. 284, 10004-10012.
9. Chien H. F., Bonifati V., and, Barbosa E. R., (2011) ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation. Mov. Disord. 26, 1364-1365.
10. Choi H. K., Won L. A., Kontur P. J., Hammond D. N., Fox A. P., Wainer B. H., Hoffmann P. C., and, Heller A., (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552, 67-76.
11. Crosiers D., Ceulemans B., Meeus B., Nuytemans K., Pals P., Van Broeckhoven C., Cras P., and, Theuns J., (2011) Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat. Disord. 17, 135-138.
12. Di Fonzo A., Chien H. F., Socal M., et al. (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68, 1557-1562. (Pubitemid 46717978)
13. Di Fonzo A., Dekker M. C., Montagna P., et al. (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72, 240-245.
14. Ebert B. L., Firth J. D., and, Ratcliffe P. J., (1995) Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270, 29083-29089.
15. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D., and, Semenza G. L., (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613. (Pubitemid 26272112)
16. Gitler A. D., Chesi A., Geddie M. L., et al. (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308-315.
17. Huang L. E., Gu J., Schau M., and, Bunn H. F., (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U S A 95, 7987-7992.
18. Keyser R. J., van der Merwe L., Venter M., Kinnear C., Warnich L., Carr J., and, Bardien S., (2009) Identification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene. BMC Med. Genet. 10, 105.
19. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and, Shimizu N., (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608. (Pubitemid 28207717)
20. Lautier C., Goldwurm S., Durr A., Giovannone B., Tsiaras W. G., Pezzoli G., Brice A., and, Smith R. J., (2008) Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am. J. Hum. Genet. 82, 822-833.
21. Lee D. W., and, Andersen J. K., (2006) Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders. Curr. Mol. Med. 6, 883-893. (Pubitemid 44883938)
22. Leroy E., Boyer R., Auburger G., et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
23. Millhorn D. E., Raymond R., Conforti L., Zhu W., Beitner-Johnson D., Filisko T., Genter M. B., Kobayashi S., and, Peng M., (1997) Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Int. 51, 527-535. (Pubitemid 27088170)
24. Morgan N. V., Westaway S. K., Morton J. E., et al. (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 38, 752-754. (Pubitemid 43980594)
25. Nelson J. D., Denisenko O., and, Bomsztyk K., (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179-185.
26. Ning Y. P., Kanai K., Tomiyama H., et al. (2008) PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 70, 1491-1493. (Pubitemid 351521945)
27. Paisan-Ruiz C., Jain S., Evans E. W., et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600. (Pubitemid 39531224)
28. Park J. S., Mehta P., Cooper A. A., et al. (2011) Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset Parkinsonism. Hum. Mutat. 32, 956-964.
29. Polymeropoulos M. H., Lavedan C., Leroy E., et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. (Pubitemid 27443610)
30. Ramirez A., Heimbach A., Grundemann J., et al. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191. (Pubitemid 44470365)
31. Salceda S., and, Caro J., (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647. (Pubitemid 27386079)
32. Santoro L., Breedveld G. J., Manganelli F., et al. (2011) Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability. Neurogenetics 12, 33-39.
33. Schneider S. A., Paisan-Ruiz C., Quinn N. P., Lees A. J., Houlden H., Hardy J., and, Bhatia K. P., (2010) ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov. Disord. 25, 979-984.
34. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L. E., and, Song W., (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U S A 103, 18727-18732. (Pubitemid 44913478)
35. Tacchini L., Bianchi L., Bernelli-Zazzera A., and, Cairo G., (1999) Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142-24146.
36. Valente E. M., Abou-Sleiman P. M., Caputo V., et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160. (Pubitemid 38661852)
37. Wang G. L., Jiang B. H., Rue E. A., and, Semenza G. L., (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U S A 92, 5510-5514.
38. Wykoff C. C., Beasley N. J., Watson P. H., et al. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60, 7075-7083. (Pubitemid 32059187)
39. Yamakawa M., Liu L. X., Date T., et al. (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ. Res. 93, 664-673. (Pubitemid 37222163)
40. Zimprich A., Biskup S., Leitner P., et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607. (Pubitemid 39531225)